高压氧联合布地奈德福莫特罗粉吸入剂治疗成人支气管哮喘的临床观察

Clinical observation of hyperbaric oxygen combined budesonide and formoterol fumarate powder for inhalation treatment of adult patients with bronchial asthma

目的探讨高压氧联合布地奈德福莫特罗粉吸入剂治疗成人支气管哮喘的临床疗效。方法分析我院2013年1月~2014年8月收治的60例支气管哮喘的患者临床资料,依据治疗方法不同进行临床随机分组,常规治疗组30例和联合治疗组30例。结果两组支气管哮喘患者治疗前动脉血气分析结果、肺功能无明显差异（P〉0.05）,联合治疗组治疗后动脉血气分析结果、肺功能均优于常规治疗组,联合治疗组发作频率和程度均优于常规治疗组,差异有统计学意义（P〈0.05）。结论高压氧联合布地奈德福莫特罗粉吸入剂治疗成人支气管哮喘临床症状改善明显,预后良好,值得临床推广应用。

Objective To study the clinical effect of hyperbaric oxygen combined budesonide and formoterol fumarate powder for inhalation in the treatment of adult patients with bronchial asthma. Methods 60 adult patients with bronchial asthma who were treated in our hospital from January 2013 to August 2014, were analyzed as the clinical data, were randomly divided into two groups according to the different treatment methods, with 30 cases in routine treatment group and 30 cases in combined treatment group. Results The analysis results of arterial blood gas and pulmonary function before the treatment of adult patients with bronchial asthma between the two groups were no significant differences（P〉0.05）, while which after treatment in combined treatment group was better than which in routine treatment group（P 〈 0.05）. The seizure frequency and degree in combined treatment group was better than which in routine treatment group, the difference was statically significant（P〈0.05）. Conclusion Hyperbaric oxygen combined budesonide and formoterol fumarate powder for inhalation in the treatment of adult patients with bronchial asthma has obviously improved the clinical effect, has favourable prognosis, is worthy of clinical popularization and application.